Therapies negating neuroinflammation after brain trauma.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Brain Research

• Publication date

  2016-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.brainres.2015.12.024PMID 26740405
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• P 1-c 16 Identification of novel UCH-L 1-potentiating compounds by in silico drug screening

  2018cited by this paper
• Treatment of traumatic brain injury with anti-inflammatory drugs.

  2016cited by this paper
• Microglial/Macrophage Polarization Dynamics following Traumatic Brain Injury

  2016cited by this paper
• Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial.

  2015cited by this paper
• Long-Term Consequences of Traumatic Brain Injury: Current Status of Potential Mechanisms of Injury and Neurological Outcomes

  2015cited by this paper
• Inflammatory reaction after traumatic brain injury: therapeutic potential of targeting cell-cell communication by chemokines.

  2015influential reference
• Soluble or soluble/membrane TNF-± inhibitors protect the brain from focal ischemic injury in rats

  2015cited by this paper
• Erythropoietin dampens injury-induced microglial motility

  2015cited by this paper
• Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies.

  2015cited by this paper
• Blood Biomarkers in Moderate-To-Severe Traumatic Brain Injury: Potential Utility of a Multi-Marker Approach in Characterizing Outcome

  2015cited by this paper
• Chronic Inflammation After Severe Traumatic Brain Injury: Characterization and Associations With Outcome at 6 and 12 Months Postinjury

  2015cited by this paper
• Interleukin-1 and acute brain injury

  2015cited by this paper
• Transiently lowering tumor necrosis factor-α synthesis ameliorates neuronal cell loss and cognitive impairments induced by minimal traumatic brain injury in mice

  2015cited by this paper
• CCR2 Antagonism Alters Brain Macrophage Polarization and Ameliorates Cognitive Dysfunction Induced by Traumatic Brain Injury

  2015cited by this paper
• EPO in traumatic brain injury: two strikes…but not out?

  2015cited by this paper
• Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial.

  2014cited by this paper
• A clinical trial of progesterone for severe traumatic brain injury.

  2014cited by this paper
• Erythropoietin for traumatic brain injury.

  2014influential reference
• Effect of etanercept and lithium chloride on preventing secondary tissue damage in rats with experimental diffuse severe brain injury.

  2014cited by this paper
• International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors

  2014cited by this paper
• Inhibition of infection-mediated preterm birth by administration of broad spectrum chemokine inhibitor in mice

  2014influential reference
• Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence

  2014cited by this paper
• Very early administration of progesterone for acute traumatic brain injury.

  2014cited by this paper
• CCR2 Deficiency Impairs Macrophage Infiltration and Improves Cognitive Function after Traumatic Brain Injury

  2014cited by this paper
• Comment on: “Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence”

  2014cited by this paper
• Chronic Neurodegeneration After Traumatic Brain Injury: Alzheimer Disease, Chronic Traumatic Encephalopathy, or Persistent Neuroinflammation?

  2014cited by this paper
• Authors’ Reply to Whitlock: Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence

  2014cited by this paper
• Recombinant Human Interleukin-1 Receptor Antagonist in Severe Traumatic Brain Injury: A Phase II Randomized Control Trial

  2014cited by this paper
• Comparison of the Effect of Minocycline and Simvastatin on Functional Recovery and Gene Expression in a Rat Traumatic Brain Injury Model

  2014influential reference
• Immediate Neurological Recovery Following Perispinal Etanercept Years After Brain Injury

  2014cited by this paper
• Diffusion Tensor Imaging for Outcome Prediction in Mild Traumatic Brain Injury: A TRACK-TBI Study

  2014cited by this paper
• Endothelial Nitric Oxide Synthase Mediates the Cerebrovascular Effects of Erythropoietin in Traumatic Brain Injury

  2014cited by this paper
• Acute over-the-counter pharmacological intervention does not adversely affect behavioral outcome following diffuse traumatic brain injury in the mouse

  2014cited by this paper
• The Physiologic Effects of Indomethacin Test on CPP and ICP in Severe Traumatic Brain Injury (sTBI)

  2014cited by this paper
• Interleukin-1 Receptor Blockade in Perinatal Brain Injury

  2014cited by this paper
• The neuroinflammatory response in humans after traumatic brain injury

  2013cited by this paper
• The Role of Markers of Inflammation in Traumatic Brain Injury

  2013influential reference
• Microglia/Macrophage Polarization Dynamics in White Matter after Traumatic Brain Injury

  2013cited by this paper
• Substance P antagonists as a novel intervention for brain edema and raised intracranial pressure.

  2013cited by this paper
• Etanercept attenuates traumatic brain injury in rats by reducing early microglial expression of tumor necrosis factor-α

  2013cited by this paper
• Etanercept Attenuates Traumatic Brain Injury in Rats by Reducing Brain TNF-α Contents and by Stimulating Newly Formed Neurogenesis

  2013cited by this paper
• Erythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor

  2013cited by this paper
• Comparison of the effects of erythropoietin and anakinra on functional recovery and gene expression in a traumatic brain injury model

  2013cited by this paper
• Blockade of CXCR1/2 chemokine receptors protects against brain damage in ischemic stroke in mice

  2013cited by this paper
• Soluble TNF Receptor 1-Secreting ex Vivo-Derived Dendritic Cells Reduce Injury After Stroke

  2013influential reference
• TNF-alpha receptor antagonist, R-7050, improves neurological outcomes following intracerebral hemorrhage in mice.

  2013influential reference
• Chemokine CCL2 Induces Apoptosis in Cortex Following Traumatic Brain Injury

  2013influential reference
• Cytokine Gene Polymorphisms and Outcome after Traumatic Brain Injury

  2013cited by this paper
• Reactive Oxygen Species-Activated Nanoprodrug of Ibuprofen for Targeting Traumatic Brain Injury in Mice

  2013cited by this paper
• Repetitive mild traumatic brain injury augments tau pathology and glial activation in aged hTau mice.

  2013cited by this paper
• Traumatic brain injury in aged animals increases lesion size and chronically alters microglial/macrophage classical and alternative activation states.

  2013cited by this paper
• Tumor necrosis factor alpha antagonism improves neurological recovery in murine intracerebral hemorrhage

  2013influential reference
• Effects of selective and non-selective cyclooxygenase inhibition against neurological deficit and brain oedema following closed head injury in mice.

  2013cited by this paper
• Emerging Role of Endosomal Toll-Like Receptors in Rheumatoid Arthritis

  2013cited by this paper
• Changes in Brain Tissue Oxygenation After Treatment of Diffuse Traumatic Brain Injury by Erythropoietin*

  2013cited by this paper
• Inflammation and white matter degeneration persist for years after a single traumatic brain injury.

  2013cited by this paper
• Targeting interleukin-1β in CAPS (cryopyrin-associated periodic) syndromes: what did we learn?

  2012cited by this paper
• Evaluation of late cognitive impairment and anxiety states following traumatic brain injury in mice: the effect of minocycline.

  2012cited by this paper
• Etanercept: efficacy and safety for approved indications

  2012cited by this paper
• Delayed Administration of Interleukin-1 Receptor Antagonist Reduces Ischemic Brain Damage and Inflammation in Comorbid Rats

  2012cited by this paper
• Acute Minocycline Treatment Mitigates the Symptoms of Mild Blast-Induced Traumatic Brain Injury

  2012cited by this paper
• Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

  2012influential reference
• Indomethacin protects rats from neuronal damage induced by traumatic brain injury and suppresses hippocampal IL-1β release through the inhibition of Nogo-A expression

  2012cited by this paper
• Emerging Imaging Tools for Use with Traumatic Brain Injury Research

  2012cited by this paper
• Use of Serum Biomarkers to Predict Secondary Insults Following Severe Traumatic Brain Injury

  2012cited by this paper
• Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury.

  2012cited by this paper
• Etanercept, a Widely Used Inhibitor of Tumor Necrosis Factor-α (TNF- α), Prevents Retinal Ganglion Cell Loss in a Rat Model of Glaucoma

  2012cited by this paper
• Attenuation of Microglial Activation with Minocycline Is Not Associated with Changes in Neurogenesis after Focal Traumatic Brain Injury in Adult Mice

  2012cited by this paper
• Selective TNF Inhibition for Chronic Stroke and Traumatic Brain Injury: An Observational Study Involving 629 Consecutive Patients Treated with Perispinal Etanercept

  2012cited by this paper
• Brain Protection from Stroke with Intravenous TNFα Decoy Receptor-Trojan Horse Fusion Protein

  2012influential reference
• Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study.

  2012cited by this paper
• Selective TNF Inhibition for Chronic Stroke and Traumatic Brain Injury

  2012cited by this paper
• Ibuprofen attenuates the inflammatory response and allows formation of migratory neuroblasts from grafted stem cells after traumatic brain injury

  2012cited by this paper
• Substance P-induced changes in cell genesis following diffuse traumatic brain injury.

  2012cited by this paper
• Guilty Molecules, Guilty Minds? The Conflicting Roles of the Innate Immune Response to Traumatic Brain Injury

  2012cited by this paper
• Postnatal administration of IL-1Ra exerts neuroprotective effects following perinatal inflammation and/or hypoxic-ischemic injuries.

  2012cited by this paper
• A substance P antagonist improves outcome when administered 4 h after onset of ischaemic stroke.

  2011cited by this paper
• Interleukin‐1 type 1 receptor/Toll‐like receptor signalling in epilepsy: the importance of IL‐1beta and high‐mobility group box 1

  2011cited by this paper
• Beneficial Effect of Erythropoietin on Sensorimotor Function and White Matter After Hypoxia-Ischemia in Neonatal Mice

  2011cited by this paper
• Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury

  2011influential reference
• Reduced brain edema and functional deficits after treatment of diffuse traumatic brain injury by carbamylated erythropoietin derivative*

  2011cited by this paper
• Neutralization of interleukin‐1β reduces cerebral edema and tissue loss and improves late cognitive outcome following traumatic brain injury in mice

  2011cited by this paper
• Differences in Cerebral Extracellular Response of Interleukin-1β, Interleukin-6, and Interleukin-10 After Subarachnoid Hemorrhage or Severe Head Trauma in Humans

  2011cited by this paper
• Inflammation after trauma: Microglial activation and traumatic brain injury

  2011cited by this paper
• Inhibition of CXCR1 and CXCR2 chemokine receptors attenuates acute inflammation, preserves gray matter and diminishes autonomic dysreflexia after spinal cord injury

  2011influential reference
• Tumor necrosis factor‐α synthesis inhibitor, 3,6′‐dithiothalidomide, reverses behavioral impairments induced by minimal traumatic brain injury in mice

  2011cited by this paper
• Dose-dependent neurorestorative effects of delayed treatment of traumatic brain injury with recombinant human erythropoietin in rats.

  2011cited by this paper
• A Substance P Antagonist Reduces Axonal Injury and Improves Neurologic Outcome When Administered Up to 12 Hours after Traumatic Brain Injury

  2011cited by this paper
• What is a systematic review?

  2011cited by this paper
• Substance P antagonists as a therapeutic approach to improving outcome following traumatic brain injury

  2011cited by this paper
• Regulation of interleukin-1 in acute brain injury.

  2011cited by this paper
• The Cytokine Response to Human Traumatic Brain Injury: Temporal Profiles and Evidence for Cerebral Parenchymal Production

  2011cited by this paper
• Effect of recombinant human erythropoietin on serum S100B protein and interleukin-6 levels after traumatic brain injury in the rat.

  2010cited by this paper
• Therapeutic evaluation of etanercept in a model of traumatic brain injury

  2010cited by this paper
• Blockade of Acute Microglial Activation by Minocycline Promotes Neuroprotection and Reduces Locomotor Hyperactivity after Closed Head Injury in Mice: A Twelve-Week Follow-Up Study

  2010influential reference
• Sprouting of corticospinal tract axons from the contralateral hemisphere into the denervated side of the spinal cord is associated with functional recovery in adult rat after traumatic brain injury and erythropoietin treatment.

  2010cited by this paper
• Deficiency of the chemokine receptor CXCR2 attenuates neutrophil infiltration and cortical damage following closed head injury.

  2010cited by this paper
• Perispinal etanercept: a new therapeutic paradigm in neurology

  2010cited by this paper
• Safety and Efficacy of Erythropoietin in Traumatic Brain Injury Patients: A Pilot Randomized Trial

  2010cited by this paper
• Post-Traumatic Hypoxia Exacerbates Brain Tissue Damage: Analysis of Axonal Injury and Glial Responses

  2010cited by this paper

• Updates on first- and second-generation antidepressants used in the treatment of traumatic brain injury-induced depression.

  2025cites this paper
• Multimodal Imaging Markers of Cognitive Resilience and Molecular Mechanisms of Brain Resilience in Alzheimer's Disease.

  2025cites this paper
• The paradigm of stem cell secretome in tissue repair and regeneration: Present and future perspectives

  2025cites this paper
• GsMTx4 Mitigates Neuroinflammation and Promotes Functional Recovery by Maintaining Microenvironmental Homeostasis During the Acute Phase After Traumatic Brain Injury in Mice

  2025cites this paper
• Progesterone induces neuroprotection associated with immune/inflammatory modulation in experimental traumatic brain injury

  2024cites this paper
• The evolving pathophysiology of TBI and the advantages of temporally-guided combination therapies.

  2024cites this paper
• Candidate Molecular Biomarkers of Traumatic Brain Injury: A Systematic Review

  2024cites this paper
• Lactobacillus Helveticus Improves Controlled Cortical Impact Injury-Generated Neurological Aberrations by Remodeling of Gut-Brain Axis Mediators

  2024cites this paper
• Inflammatory Signaling Induces Mitochondrial Dysfunction and Neuronal Death in Traumatic Brain Injury via Downregulation of OXPHOS Genes

  2024cites this paper
• Traumatic Brain Injury and Traumatic Spinal Cord Injury

  2024cites this paper
• Antidiabetic Drugs Can Reduce the Harmful Impact of Chronic Smoking on Post-Traumatic Brain Injuries

  2023cites this paper
• Myelin degradation, axonal changes and expression trajectories of glial cells stimulated by rapid head insult in humans to estimate approximate time elapsed since trauma

  2023cites this paper
• The mechanism of chemokine receptor ACKR2 in cognitive impairment in young rats with traumatic brain injury.

  2023cites this paper
• A combination of umbilical cord mesenchymal stem cells and monosialotetrahexosy 1 ganglioside alleviates neuroinflammation in traumatic brain injury

  2023cites this paper
• Anti-inflammatory effect of P2Y1 receptor blocker MRS2179 in a rat model of traumatic brain injury.

  2022cites this paper
• TREM2 activation alleviates neural damage via Akt/CREB/BDNF signalling after traumatic brain injury in mice

  2022cites this paper
• Emerging role of STING signalling in CNS injury: inflammation, autophagy, necroptosis, ferroptosis and pyroptosis

  2022cites this paper
• A Focal Impact Model of Traumatic Brain Injury in Xenopus Tadpoles Reveals Behavioral Alterations, Neuroinflammation, and an Astroglial Response

  2022cites this paper
• Evaluation of Computed Tomography Scoring Systems in the Prediction of Short-Term Mortality in Traumatic Brain Injury Patients from a Low- to Middle-Income Country

  2022cites this paper
• Correcting a widespread error: Neuroprotectant N-acetyl-L-tryptophan does not bind to the neurokinin-1 receptor.

  2022cites this paper
• Hydroxychloroquine attenuates neuroinflammation following traumatic brain injury by regulating the TLR4/NF-κB signaling pathway

  2022cites this paper
• Inflammation, Neurovascular Clearance and Associated Pathologies: A Translational Review Focusing on Traumatic Brain Injury

  2021cites this paper
• Hyperbaric oxygen therapy improves neurological function via the p38-MAPK/CCL2 signaling pathway following traumatic brain injury

  2021cites this paper
• A Pro-social Pill? The Potential of Pharmacological Treatments to Improve Social Outcomes After Pediatric Traumatic Brain Injury

  2021cites this paper
• The binding and specificity of chemokine binding proteins, through the lens of experiment and computation

  2021cites this paper
• Mismatch between midline shift and hematoma thickness as a prognostic factor of mortality in patients sustaining acute subdural hematoma

  2021cites this paper
• Neuropharmacology in traumatic brain injury: from preclinical to clinical neuroprotection?

  2021cites this paper
• veVEGI Improves Outcomes in the Early Phase of Experimental Traumatic Brain Injury.

  2020cites this paper
• First‐in‐Human Studies of MW01‐6‐189WH, a Brain‐Penetrant, Antineuroinflammatory Small‐Molecule Drug Candidate: Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Studies in Healthy Adult Volunteers

  2020cites this paper
• A Novel Highly Sensitive Method for Measuring Inflammatory Neural-Derived APC Activity in Glial Cell Lines, Mouse Brain and Human CSF

  2020cites this paper
• Blast traumatic brain injury and serum inflammatory cytokines: a repeated measures case-control study among U.S. military service members

  2020cites this paper
• Cellular infiltration in traumatic brain injury

  2020cites this paper
• A multi-staged neuropeptide response to traumatic brain injury

  2020cites this paper
• Genetically Modified Mesenchymal Stem Cells: The Next Generation of Stem Cell-Based Therapy for TBI

  2020cites this paper
• Elevated intracranial pressure after head trauma can be suppressed by antisecretory factor—a pilot study

  2020influential citation
• RNA-seq analysis and compound screening highlight multiple signalling pathways regulating secondary cell death after acute CNS injury in vivo

  2020influential citation
• Neurological Effects of Repeated Exposure to Military Occupational Levels of Blast: A Review of Scientific Literature

  2020cites this paper
• A Systematic Review of Large Animal Models of Combined Traumatic Brain Injury and Hemorrhagic Shock.

  2019cites this paper
• Role of Toll-like receptor mediated signaling in traumatic brain injury.

  2019cites this paper
• Inflammatory cytokines are involved in dihydrocapsaicin (DHC) and regional cooling infusion (RCI)-induced neuroprotection in ischemic rat.

  2019cites this paper
• Metabolism and inflammation: implications for traumatic brain injury therapeutics

  2019cites this paper
• Nicotinamide Improves Functional Recovery via Regulation of the RAGE/JNK/NF-κB Signaling Pathway after Brain Injury

  2019cites this paper
• Acute Inflammation After Traumatic Brain Injury

  2019cites this paper
• Acute Inflammation in Traumatic Brain Injury and Polytrauma Patients Using Network Analysis.

  2019cites this paper
• Modelling human pathology of traumatic brain injury in animal models

  2019cites this paper
• Deletion of p38α MAPK in microglia blunts trauma-induced inflammatory responses in mice

  2019cites this paper
• Docosahexaenoic acid decreased neuroinflammation in rat pups after controlled cortical impact.

  2019influential citation
• 2-BFI Provides Neuroprotection Against Inflammation and Necroptosis in a Rat Model of Traumatic Brain Injury

  2019cites this paper
• Immune-Based Therapies for Traumatic Brain Injury: Insights from pre-clinical studies.

  2019cites this paper
• Neurologic and Psychiatric Effects of Cytokines and Targeted Biological Therapies

  2019cites this paper
• Geniposide Alleviates Traumatic Brain Injury in Rats Via Anti-Inflammatory Effect and MAPK/NF-kB Inhibition

  2019cites this paper
• Intravenously Infusing the Secretome of Adipose-Derived Mesenchymal Stem Cells Ameliorates Neuroinflammation and Neurological Functioning After Traumatic Brain Injury

  2019cites this paper
• Bilateral Vestibular Dysfunction Associated With Chronic Exposure to Military Jet Propellant Type-Eight Jet Fuel

  2019influential citation
• Profiling Brain Trauma in Professional American-style Football and the Implications to Developing Neurological Injury

  2019cites this paper
• MicroRNA let-7c-5p improves neurological outcomes in a murine model of traumatic brain injury by suppressing neuroinflammation and regulating microglial activation.

  2018cites this paper
• Chronic Pain After Traumatic Brain Injury: Pathophysiology and Pain Mechanisms

  2018cites this paper
• Perispinal etanercept advances as a neurotherapeutic

  2018cites this paper
• Schädel-Hirn-Trauma: Einfluss auf die unfallchirurgische Akutversorgung

  2018cites this paper
• Gambogic amide, a selective TrkA agonist, does not improve outcomes from traumatic brain injury in mice

  2018cites this paper
• Systemic Inflammation and Cerebral Dysfunction

  2018cites this paper
• STING-mediated type-I interferons contribute to the neuroinflammatory process and detrimental effects following traumatic brain injury

  2018cites this paper
• Neurotransmitter changes after traumatic brain injury: an update for new treatment strategies

  2018cites this paper
• Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities

  2018cites this paper
• Depression following a traumatic brain injury: uncovering cytokine dysregulation as a pathogenic mechanism

  2018cites this paper
• Hyperbaric Oxygen Alleviates the Inflammatory Response Induced by LPS Through Inhibition of NF-κB/MAPKs-CCL2/CXCL1 Signaling Pathway in Cultured Astrocytes

  2018cites this paper
• Interferons in Traumatic Brain and Spinal Cord Injury: Current Evidence for Translational Application

  2018cites this paper
• TrkB-enhancer facilitates functional recovery after traumatic brain injury

  2017cites this paper
• Salsalate treatment following traumatic brain injury reduces inflammation and promotes a neuroprotective and neurogenic transcriptional response with concomitant functional recovery.

  2017influential citation
• 2. Barriers to translation of medical innovation

  2017cites this paper
• On Overcoming Barriers to Application of Neuroinflammation Research

  2017cites this paper
• Posttraumatic therapeutic hypothermia alters microglial and macrophage polarization toward a beneficial phenotype

  2017cites this paper
• Evaluation of novel computerized tomography scoring systems in human traumatic brain injury: An observational, multicenter study

  2017cites this paper
• Treatment with an interleukin-1 receptor antagonist mitigates neuroinflammation and brain damage after polytrauma.

  2017cites this paper
• Mesenchymal stem cells maintain the microenvironment of central nervous system by regulating the polarization of macrophages/microglia after traumatic brain injury

  2017cites this paper
• The scavenging chemokine receptor ACKR2 has a significant impact on acute mortality rate and early lesion development after traumatic brain injury

  2017cites this paper
• Osthole Enhances the Therapeutic Efficiency of Stem Cell Transplantation in Neuroendoscopy Caused Traumatic Brain Injury.

  2017cites this paper
• Elucidating Pro-Inflammatory Cytokine Responses after Traumatic Brain Injury in a Human Stem Cell Model

  2017cites this paper
• Preclinical modelling of militarily relevant traumatic brain injuries: Challenges and recommendations for future directions

  2017cites this paper
• Repetitive and Prolonged Omega-3 Fatty Acid Treatment after Traumatic Brain Injury Enhances Long-Term Tissue Restoration and Cognitive Recovery

  2017cites this paper
• Monitoring the Neuroinflammatory Response Following Acute Brain Injury

  2017influential citation
• Alteration in Long Non-Coding RNA Expression after Traumatic Brain Injury in Rats

  2017cites this paper
• Should We Stop Saying 'Glia' and 'Neuroinflammation'?

  2017cites this paper
• Traumatic Brain Injury: Preclinical Imaging Diagnostic(s) and Therapeutic Approaches.

  2017cites this paper
• Targeted Temperature Management in Non-anoxic Brain Injury

  2017cites this paper
• Galectin-3 released in response to traumatic brain injury acts as an alarmin orchestrating brain immune response and promoting neurodegeneration

  2017cites this paper
• Decreased Secondary Lesion Growth and Attenuated Immune Response after Traumatic Brain Injury in Tlr2/4−/− Mice

  2017cites this paper
• Combination therapies for neurobehavioral and cognitive recovery after experimental traumatic brain injury: Is more better?

  2016cites this paper
• Perispinal Delivery of CNS Drugs

  2016cites this paper
• Biomarkers of Traumatic Brain Injury: Temporal Changes in Body Fluids

  2016cites this paper
• The Role of Matrix Metalloproteinase 9 and Osteopontin in Synaptogenesis and Reinnervation of the Olfactory Bulb Following Brain Injury

  2016cites this paper
• Anti‐inflammatory effects of ADAMTS‐4 in a mouse model of ischemic stroke

  2016cites this paper
• Neurogenic inflammation after traumatic brain injury and its potentiation of classical inflammation

  2016cites this paper